Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00395655
What this trial is testing

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer
National Institute of Cancerología 43
Testing effectiveness (Phase 2)Looking for participantsNCT05564390
What this trial is testing

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03087227
What this trial is testing

Shared Health Information System for Febrile Neutropenia

Who this might be right for
Febrile NeutropeniaSolid TumorHematologic Neoplasms
Marie-Helene METZGER 121
Not applicableNot Yet RecruitingNCT06154590
What this trial is testing

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

Who this might be right for
Metastatic Breast CancerTumorMuscle Neoplasms+1 more
DR. DIANE CHISESI NFS. MD. PHD. 100
Early research (Phase 1)Looking for participantsNCT06914479
What this trial is testing

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Who this might be right for
Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain NeoplasmResectable Brain Neoplasm
University of Michigan Rogel Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03093350
What this trial is testing

TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Baylor College of Medicine 12
Not applicableUnknownNCT04752865
What this trial is testing

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 50
Large-scale testing (Phase 3)Study completedNCT00191438
What this trial is testing

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 300
Early research (Phase 1)Study completedNCT01945814
What this trial is testing

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

Who this might be right for
EBVCMVAdenovirus
Catherine Bollard 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04214249
What this trial is testing

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01959438
What this trial is testing

Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma

Who this might be right for
Malignant TumorTreatment Resistant DisordersTumor Progression
Karolinska University Hospital 32
Early research (Phase 1)Study completedNCT00058591
What this trial is testing

Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)

Who this might be right for
Epstein-Barr Virus Infections
Baylor College of Medicine 13
Early research (Phase 1)UnknownNCT01823718
What this trial is testing

Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes

Who this might be right for
EBV Associated Lymphoma
Nantes University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00508833
What this trial is testing

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

Who this might be right for
Hepatitis B Disease
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Looking for participantsNCT06963905
What this trial is testing

Saci Nivo Rela for TNBC

Who this might be right for
Metastatic Triple-negative Breast Cancer
Yale University 60
Not applicableUnknownNCT05596149
What this trial is testing

Assessment of the Cytotoxic and Genotoxic Effect of Toothpastes With Different Forms of Fluoride on the Buccal Mucosa

Who this might be right for
DNA Damage
University of Zagreb 80
Early research (Phase 1)Study completedNCT02239861
What this trial is testing

TAA-Specific CTLS for Solid Tumors (TACTASOM)

Who this might be right for
Rhabdomyosarcoma
Baylor College of Medicine 16
Not applicableNot Yet RecruitingNCT06772090
What this trial is testing

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Who this might be right for
Solid Tumor, AdultCytotoxicity
Masonic Cancer Center, University of Minnesota 40
Not applicableStudy completedNCT05015543
What this trial is testing

Physical Training in Glioblastoma Patients During Cytotoxic Therapy

Who this might be right for
Glioblastoma
University Hospital Muenster 54
Large-scale testing (Phase 3)Active Not RecruitingNCT03007147
What this trial is testing

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia+1 more
Children's Oncology Group 352
Next Page
2,000
49